Literature DB >> 31238751

Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression.

Matthew Li1, Ling-Yee Chin1, Sykuri Shukor1, Alfred G Tamayo1, Marcela V Maus2,3, Biju Parekkadan1,4,5.   

Abstract

Background/aim: T-cell immunotherapies are rapidly gaining grounds in clinical success. Presently, there is first-to-market knowledge on the translation of research scale methods to clinical and commercial scales. Improved understanding can lead to more consistent and efficient production, scaling, and eventual potency. T-cell checkpoint markers, proliferation, and T-cell cluster size and disaggregation are one set of parameters that have yet to be explored.
Methods: We herein activated T-cells and assessed various mechanical dissociation frequencies in relation to expression of checkpoint markers (measured by flow cytometry).
Results: We herein find increased T-cell proliferation capacity with increased dissociation frequency. We also find that with increased cluster size and duration, lower proliferation, and increased expression of checkpoint markers. Conclusions: These findings reveal new translation findings with respect to T-cell handling and production and suggest that T-cell disaggregation may be important to improved cell yields and phenotype.

Entities:  

Keywords:  CTLA4; Lag3; PD1; T-cell; TIGIT ; TIM3; biomanufacturing; checkpoint; immunotherapy

Mesh:

Substances:

Year:  2019        PMID: 31238751      PMCID: PMC6619423          DOI: 10.1080/08916934.2019.1630064

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  27 in total

Review 1.  Three-dimensional cell cultures: from molecular mechanisms to clinical applications.

Authors:  W Mueller-Klieser
Journal:  Am J Physiol       Date:  1997-10

Review 2.  Advances and challenges in stem cell culture.

Authors:  Christina McKee; G Rasul Chaudhry
Journal:  Colloids Surf B Biointerfaces       Date:  2017-07-27       Impact factor: 5.268

Review 3.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

4.  Relations between pH, oxygen partial pressure and growth in cultured cell spheroids.

Authors:  J Carlsson; H Acker
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

5.  Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.

Authors:  Ida Rasmusson; Olle Ringdén; Berit Sundberg; Katarina Le Blanc
Journal:  Exp Cell Res       Date:  2005-01-25       Impact factor: 3.905

6.  Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway.

Authors:  Junghwa Lee; Eunseon Ahn; Haydn T Kissick; Rafi Ahmed
Journal:  For Immunopathol Dis Therap       Date:  2015

7.  Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors.

Authors:  Shin Foong Ngiow; Bianca von Scheidt; Hisaya Akiba; Hideo Yagita; Michele W L Teng; Mark J Smyth
Journal:  Cancer Res       Date:  2011-03-23       Impact factor: 12.701

8.  LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.

Authors:  Joseph F Grosso; Cristin C Kelleher; Timothy J Harris; Charles H Maris; Edward L Hipkiss; Angelo De Marzo; Robert Anders; George Netto; Derese Getnet; Tullia C Bruno; Monica V Goldberg; Drew M Pardoll; Charles G Drake
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

Review 9.  Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T.

Authors:  Dok Hyun Yoon; Mark J Osborn; Jakub Tolar; Chong Jai Kim
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

10.  Oxygen transport and stem cell aggregation in stirred-suspension bioreactor cultures.

Authors:  Jincheng Wu; Mahboubeh Rahmati Rostami; Diana P Cadavid Olaya; Emmanuel S Tzanakakis
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.